WebApr 12, 2024 · Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been appointed Chi. Skip to content. 12 April، 2024 . DGN Gate. News from Dubai. Mobiles. OPPO Set To Introduce The Reno8 T Series With 108MP Portrait Camera In The GCC Market. WebIn 2024, Hikma Pharmaceuticals acquired Custopharm to expand its product portfolio and enhance its R&D capabilities. Sector Pharmaceutical and Life Sciences; Investment Date 2015; Headquarters Carlsbad, CA; CEO William C. Larkins, Jr, PhD; View Website. Additional Pharmaceutical and Life Sciences Companies.
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceut
WebApr 12, 2024 · Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been appointed Chief Executive Officer … WebApr 21, 2024 · CHICAGO, April 21, 2024 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has completed the sale of its... scsi and rics
Hikma strengthens US Injectables business through …
WebApr 19, 2024 · As part of generic drug company Hikma’s proposed $375 million acquisition of generic injectable producer Custopharm, the commission is requiring that Hikma not acquire a generic... WebThe up-front consideration of $375 million is on a cash-free, debt-free basis and is being funded from Hikma’s existing cash resources. The acquisition constitutes a Class 2 transaction pursuant to the UK Listing Rules. The gross assets of Custopharm at 31 December 2024 were $43 million. Losses before tax in the year to 31 December 2024 … WebFounded more than 40 years ago by Samih Darwazah, Hikma's purpose has always been to provide high-quality, affordable medicines to the people who need them. Based on the solid foundation we have built, we will continue to innovate and find practical solutions to transform the lives of the millions of people we serve. scs hyetograph